ADIL

Adial Pharmaceuticals Inc

2.060

+0.450+27.95%

After Hours: 1.960 -0.100 -4.85%17:35 05/19 EDT

Daily

Weekly

Monthly

Quarterly

Yearly

OPEN/PREV CLOSE1.640/1.610

TODAY RANGE1.640-2.240

VOL1.77M

MARKET CAP4.42M

52 WEEK RANGE1.310-18.90

AVG VOL (3M)146.63K

% TURNOVER82.68%

TURNOVER--

P/E (TTM)-0.2074

% RANGE37.27%

EPS(TTM)-9.9326

P/E(FORWARD)-0.3916

P/B0.8363

BVPS2.463

DIVIDEND--

P/S--

BETA--

DIV YIELD0.00%

FREE FLOAT MKT CAP4.16M

SHARES OUTSTANDING2.14M

NEXT EARNINGS08/11-08/17

FREE FLOAT2.02M

LOT SIZE1

EX-DATE02/06/2026

News

Press Releases

Financial Reports

Profile

TipRanks·6d ago
Adial Pharmaceuticals: Buy Rating Reiterated as AD04’s Precision AUD Strategy Advances; $8 Price Target Maintained
Reuters·05/11 12:38
Adial Pharmaceuticals Q1 net loss narrows on lower R&D spending
Seeking Alpha·05/11 12:33
Adial Pharmaceuticals reports Q1 results
Dow Jones·05/11 12:33
*Adial Pharmaceuticals: Runway to Fund Operating Expenses Into 2nd Half of 2026 >ADIL
Dow Jones·05/11 12:32
*Adial Pharmaceuticals 1Q Loss $2M >ADIL
Reuters·05/11 12:30
ADIAL PHARMACEUTICALS REPORTS 2026 FIRST QUARTER FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE
Reuters·05/11 12:30
ADIAL PHARMACEUTICALS Q1 NET INCOME USD -2 MILLION
Dow Jones·05/11 12:30
Press Release: Adial Pharmaceuticals Reports 2026 First Quarter Financial Results and Provides Business Update
Dow Jones·05/11 12:30
Press Release: Adial Pharmaceuticals Reports 2026 -2-
TipRanks·05/10 06:01
Adial Pharma’s Strategic Options: High-Stakes Search for a Deal Puts Share Price and Long-Term Prospects at Risk
PUBT·05/08 20:22
Adial Pharmaceuticals Q1 net loss narrows 9% to $2.02 million
TipRanks·04/29 16:56
Adial Pharmaceuticals files AD04 utility application with USPTO
TipRanks·04/27 13:29
Adial submits AD04 product application for FDA CNPV pilot program
NASDAQ·04/27 13:16
Adial Pharmaceuticals Applies For FDA Priority Voucher Program For AD04
PUBT·04/27 12:47
Adial submits AD04 application for FDA Commissioner's National Priority Voucher pilot program

Same Industry

Name/Symbol

Change%

Price

ADIL

Regeneron Pharmaceuticals

REGN

-2.05%

698.25

GridAI Tech

GRDX

-2.84%

3.760

BIONTECH

BNTX

-2.65%

89.55

United Therapeutics Corp.

UTHR

-1.25%

568.58

Vertex Pharmaceuticals Inc

VRTX

-2.99%

436.95

SIGA

Moderna

MRNA

-1.98%

49.04

Charles Riv Labs Intl Inc

CRL

-0.61%

149.93

Medpace Holdings

MEDP

+1.30%

420.67

Talphera Inc

TLPH

-5.98%

0.7973

ICLR

China Biologic

CBPO

0.00%

119.99

IQV

MOLECULAR PARTNERS AG

MOLN

-1.04%

3.800

ARCT

Gilead Sciences Inc

GILD

-1.88%

129.58

PRAH

INCY

Aptevo Therapeutics Inc

APVO

-0.52%

4.770

Biospecifics

BSTC

+0.15%

88.53

No content on the Webull website shall be considered a recommendation or solicitation for the purchase or sale of securities, options or other investment products. All information and data on the website is for reference only and no historical data shall be considered as the basis for judging future trends.